Phase II Study of Primary Chemotherapy with Anthracycline-based Regimen Followed by Nab-paclitaxel and Trastuzumab in Patients with HER2 Positive Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide; Doxorubicin; Epirubicin; Fluorouracil; Trastuzumab
- Indications Breast cancer
- Focus Therapeutic Use
- 21 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 29 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 09 Sep 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01432223).